✦ LIBER ✦

Pilot Trial of Bone-Targeted Therapy Combining Zoledronate With Fluvastatin or Atorvastatin for Patients With Metastatic Renal Cell Carcinoma

✍ Scribed by George E. Manoukian; Nizar M. Tannir; Eric Jonasch; Wei Qiao; Tamara M. Haygood; Shi-Ming Tu

Book ID: 113538990
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 562 KB
Volume: 9
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2011.07.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot trial of bone-targeted therapy wit

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-γ for metastatic renal cell carcinoma

✍ Nizar Tannir; Eric Jonasch; Lance C. Pagliaro; Paul Mathew; Arlene Siefker-Radtk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

## Abstract ## BACKGROUND. The purpose of the study was to evaluate the efficacy and safety of a bone‐targeted regimen consisting of zoledronate, thalidomide, and interferon‐γ in patients with renal cell carcinoma and bone metastases. ## METHODS. Eligible patients had radiographic evidence of bo

Efficacy of targeted therapy in patients

Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases

✍ Jakub Żołnierek; Pawel Nurzyński; Przemysław Langiewicz; Sylwia Oborska; Anna Wa 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 274 KB

Prognostic Factors of Survival for Patie

Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium

✍ Vickers, Michael M.; Al-Harbi, Hulayel; Choueiri, Toni K.; Kollmannsberger, Chri 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 314 KB

Phase I trial of sorafenib in combinatio

Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 359 KB

Economic evaluation of new targeted ther

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Erratum to: Phase I trial of sorafenib i

Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 65 KB